Enhancing Quality Standards for Indian MSME Pharmaceutical Sector

Discover the challenges faced by the Indian pharmaceutical industry in aligning with international quality standards and  how the government aims to support the industry while maintaining quality standards.

Lately, the Indian pharmaceutical industry has emerged as a global powerhouse, earning the reputation of being the pharmacy of the world. However, recent incidents involving contaminated medicines has forced the government to align the quality standards with International norms in the pharmaceutical sector, particularly among the micro, small, and medium enterprises (MSMEs).

Alongside, Union Health Ministry notification of the Revised Schedule M, the new guidelines mandate the implementation of stringent quality control measures, including an annual Product Quality Review (PQR), Quality Risk Management (QRM), and a Pharmaceutical Quality
System (PQM). Whilst, these measures are crucial for maintaining the industry & global competitiveness, their implementation poses a challenge for the MSME sector.

Recognizing the financial constraints faced by MSMEs, the Department of Pharmaceuticals has proposed a Pharmaceutical Technology Upgradation Assistance Scheme. This scheme aims to provide financial assistance to MSMEs to upgrade their facilities and comply with the new quality standards. The MSME sector has voiced its concerns regarding the timeline and financial requirements for implementing the Revised Schedule M of the Drugs and Cosmetics Rules, 1945, notified by the Union Health Ministry on January 6th, which prescribes the Good Manufacturing Practices (GMP) for pharmaceutical products. Upgrading infrastructure, adopting new technologies, and training personnel can be a significant financial burden for MSMEs.

While the government had provided ample time by releasing the draft guidelines in 2018, the MSMEs have requested an extension of the compliance timeline and additional financial incentives. It is imperative to address these concerns and support the MSME sector in this transition by providing financial assistance and a reasonable timeline for compliance, the government can ensure that the quality standards are upheld without compromising the ability of MSMEs to continue their operations and meet the demand for affordable medicines as the Indian pharmaceutical industry's success story has been built on the contributions of both large corporations and MSMEs. Striking the right balance between maintaining quality standards and supporting the growth of MSMEs is crucial for the industry's long-term sustainability and global competitiveness.